Journal of Microbial & Biochemical Technology

Metabolic Pathway Engineering of Escherichia coli for Enhanced Production of Bioplastics from Renewable Biomass

Lianghong Zhou^* Department of Chemical Engineering, University of Waterloo, Waterloo, Canada
^*Correspondence: Lianghong Zhou, Department of Chemical Engineering, University of Waterloo, Waterloo, Canada, Email:

Received: 01-Feb-2025, Manuscript No. JMBT-24-27270; Editor assigned: 03-Jan-2025, Pre QC No. JMBT-24-27270; Reviewed: 11-Jan-2025, QC No. JMBT-24-27270; Revised: 17-Jan-2025, Manuscript No. JMBT-24-27270; Published: 25-Jan-2025, DOI: 10.35248/ 1948-5948.25.17.636

Description

This study investigates the metabolic pathway engineering of Escherichia coli ( E. coli) to optimize its ability to produce bioplastics from renewable biomass sources. Bioplastics, made from biological materials, represent a sustainable alternative to conventional plastics derived from fossil fuels. The objective is to enhance the metabolic pathways involved in the synthesis of bioplastics, specifically Poly Hydroxy Alkanoates (PHAs), by genetically modifying E. coli to improve substrate utilization and yield. The research begins by exploring various types of renewable biomass, such as agricultural residues and food waste, as potential feedstocks for bioplastic production. The composition and availability of these substrates are assessed to determine their suitability for fermentation processes. This initial phase is crucial for identifying cost-effective and environmentally friendly sources of carbon that can be converted into bioplastics. Next, the study investigates the key metabolic pathways responsible for PHA biosynthesis in E. coli. Utilizing bioinformatics tools and pathway mapping, researchers identify bottlenecks and inefficiencies in the current metabolic framework. This analysis helps pinpoint specific genes and enzymatic activities that can be targeted for engineering to enhance PHA production. To achieve this, synthetic biology techniques are employed to engineer specific genes involved in the PHA biosynthetic pathway. Techniques such as CRISPR/Cas9 and plasmid-based expression systems are utilized to enhance gene expression and pathway flux. These genetic modifications aim to increase the efficiency of substrate conversion and maximize the yield of bioplastics during fermentation.

The engineered strains of E. coli undergo fermentation experiments to assess their performance in converting renewable biomass into PHAs. Various fermentation conditions, including pH, temperature, and nutrient availability, are optimized to maximize PHA yield. This optimization process is vital for developing scalable and economically viable bioprocesses. Following fermentation, the produced bioplastics are characterized using techniques such as Nuclear Magnetic Resonance (NMR), Gel Permeation Chromatography (GPC), and Scanning Electron Microscopy (SEM). These analyses determine the structural properties, molecular weight, and biodegradability of the bioplastics, ensuring that they meet industry standards for performance and environmental sustainability. Finally, the evaluation of economic feasibility and environmental benefits of using engineered E. coli for bioplastic production compared to traditional methods is conducted. Life Cycle Assessments (LCAs) highlight the sustainability aspects of this bioprocess, demonstrating its potential to reduce reliance on fossil fuels and minimize environmental pollution. Overall, this research contributes to the development of sustainable bioplastic production technologies that leverage renewable resources, reduce environmental pollution, and promote circular economy practices. The findings are expected to provide valuable insights into microbial biotechnology and metabolic engineering, paving the way for further advancements in bioplastic manufacturing.

Building upon the promising outcomes of engineered E. coli strains for PHA production, the study further investigates strategies for scaling up the process from laboratory to industrial levels. Pilot-scale bioreactors are introduced to evaluate the reproducibility and consistency of PHA synthesis under semiindustrial conditions. These scaled experiments help in understanding the influence of factors such as oxygen transfer rate, agitation speed, and feedstock loading on microbial performance and product yield. By modeling kinetic parameters and performing real-time monitoring of bioreactor conditions, the study establishes protocols for maintaining microbial stability and sustained productivity over extended fermentation cycles. Moreover, the integration of waste valorization into the bioplastic production pipeline is explored. Co-fermentation approaches using mixed biomass substrates such as combining lignocellulosic hydrolysates with food industry byproducts are assessed to improve overall carbon conversion efficiency. This strategy not only diversifies the input feedstocks but also increases the robustness of the bioprocess, making it adaptable to seasonal or regional variations in biomass availability. A critical part of the research involves engineering microbial tolerance to common fermentation inhibitors, such as furfural, acetic acid, and phenolic compounds, which are often present in pretreated agricultural residues. Through adaptive evolution and gene editing, strains of E. coli are developed with enhanced resistance to such stressors, thus improving cell viability and bioplastic yield in real-world biomass applications. From a regulatory and commercialization perspective, the study discusses biosafety and GMO containment strategies, including the use of suicide genes and dependency circuits to ensure that genetically modified organisms do not persist outside controlled environments. This aspect is especially important for public acceptance and environmental safety during industrial deployment. In terms of broader implications, this work contributes to the bioeconomy and circular resource utilization by transforming low-value waste into high-value, biodegradable plastics. It aligns with global sustainability goals such as reducing greenhouse gas emissions, promoting renewable energy solutions, and minimizing plastic pollution in terrestrial and marine ecosystems. Additionally, the insights gained into pathway engineering, synthetic biology, and systems optimization serve as a foundation for future research into the microbial production of other biopolymers and green chemicals.

References

1. Poulos TL. Heme enzyme structure and function. Chemical reviews. 2014;114(7):3919-3962.

   [CrossRef] [Google Scholar] [PubMed]

2. Beas JZ, Videira MA, Saraiva LM. Regulation of bacterial haem biosynthesis. Coordination chemistry reviews. 2022; 214452:214286.

   [Google Scholar] [CrossRef] 

3. Celis AI, DuBois JL. Making and breaking heme. Current opinion in structural biology. 2019;59:19-28.

   [Google Scholar] [CrossRef] [PubMed]

4. Koreny L, Oborník M, Horakova E, Waller RF, Lukes J. The convoluted history of haem biosynthesis. Biological Reviews. 2022;97(1):141-162.

   [Google Scholar] [CrossRef] [PubMed]

5. Phillips JD. Heme biosynthesis and the porphyrias. Molecular genetics and metabolism. 2019;128(3):164-77.

   [Google Scholar] [CrossRef]

6. Anzaldi LL, Skaar EP. Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens. Infection and immunity. 2010;78(12):4977-89.

   [Google Scholar] [CrossRef] [PubMed]

7. Layer G. Heme biosynthesis in prokaryotes. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2021;1868(1):118861.

   [Google Scholar] [CrossRef] [PubMed]

8. Di Pierro E, De Canio M, Mercadante R, Savino M, Granata F, Tavazzi D, et al. Laboratory diagnosis of porphyria. Diagnostics. 2021;11(8):1343.

   [Google Scholar] [CrossRef]

9. Al-Hussaini A, Asery A, Alharbi O. Urinary coproporphyrins as a diagnostic biomarker of Dubin-Johnson syndrome in neonates: A diagnostic pathway is proposed. Saudi Journal of Gastroenterology. 2023;29(3):183-90.

   [Google Scholar] [CrossRef] [PubMed]

10. Arab B, Westbrook AW, Moo-Young M, Liu Y, Chou CP. Bio-Based Production of Uroporphyrin in Escherichia coli. Synthetic Biology and Engineering. 2024;2(1):10002.

    [Google Scholar] [CrossRef]